Nadler Financial Group, Inc. Sab Biotherapeutics, Inc. Transaction History

Nadler Financial Group, Inc.

  • $906 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023
BUY
$0.54 - $9.8 $7,425 - $134,750
13,750 New
13,750 $8,000
Q1 2022

May 05, 2022
SELL
$1.78 - $8.5 $19,580 - $93,500
-11,000 Closed
0 $0
Q4 2021

Jan 18, 2022
BUY
$7.3 - $11.24 $80,300 - $123,640
11,000 New
11,000 $86,000

Others Institutions Holding SABS

# of Institutions
3
Shares Held
529K
Call Options Held
0
Put Options Held
0
View Full List

About SAB Biotherapeutics, Inc.

SABS Quotes by TradingView
  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $133M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Nadler Financial Group, Inc. Portfolio

Follow Nadler Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nadler Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email